Interesting CEO mentions future growth engines then states they’ve employed x2 cardiologists to look for JV in US.
JV or purchase Artrya AYA.ax ($20m current cap - balance sheet cash $20m) overlay they “Near” commercial applications for cardiologists from PME US customers, arm them with the rebate, create market share and stickiness. Rinse and repeat they’re scanning cloud systems with other platforms that fit over the top. Growing into more than a cloud provider… thoughts?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$309.98 |
Change
2.090(0.68%) |
Mkt cap ! $32.38B | |||
| Open | High | Low | Value | Volume |
| $309.99 | $310.98 | $304.01 | $43.08M | 139.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 16 | $309.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $309.98 | 2897 | 1 |
View Market Depth
| Last trade - 16.18pm 07/07/2025 (20 minute delay) ? |
| PME (ASX) Chart |